Skip to menu Skip to content Skip to footer

2016

Conference Publication

MUC13 protects colorectal cancer cells from death by activating the NF-Kb pathway and is a potential therapeutic target

Sheng, Yong H., He, Yaowu, Hasnain, Sumaira Z., Wang, Ran, Tong, Hui, Clarke, Daniel T., Lourie, Rohan, Oancea, Lulia, Wong, Kuanyau, Lumley, John W., Florin, Timothy H., Sutton, Philip, Hooper, John. D., Mcmillan, Nigel A. and Mcguckin, Michael A. (2016). MUC13 protects colorectal cancer cells from death by activating the NF-Kb pathway and is a potential therapeutic target. AACR 107th Annual Meeting on Bioinformatics and Systems Biology, New Orleans, Los Angeles, 16-20 April 2016 . Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2016-3564

MUC13 protects colorectal cancer cells from death by activating the NF-Kb pathway and is a potential therapeutic target

2016

Conference Publication

The role of cancer stem cells in colorectal cancer metastasis

Kemp, M. C., Pummer, J., He, Y., Hooper, J., Reuter, B., Borgovan, T., Zhang, X., Sullivan, R., Maresh, G., Green, H., Del Valle, L., Margolin, D. and Li, L. (2016). The role of cancer stem cells in colorectal cancer metastasis. Southern Regional Meeting of the American Federation for Medical Research (AFMR), New Orleans, LA, United States, Feb 18-20, 2016. London, United Kingdom: BMJ Group. doi: 10.1136/jim-2015-000035.415

The role of cancer stem cells in colorectal cancer metastasis

2016

Conference Publication

Targeting Apoptosis as a Novel Therapy for Myc-Driven Medulloblastoma

Ji, Pengxiang, Genovesi, Laura, He, Yaowu, Hooper, John and Wainwright, Brandon (2016). Targeting Apoptosis as a Novel Therapy for Myc-Driven Medulloblastoma. 17th International Symposium on Pediatric Neuro-Oncology (ISPNO), Liverpool England, 12-15 June 2016. United States: Oxford University Press.

Targeting Apoptosis as a Novel Therapy for Myc-Driven Medulloblastoma

2015

Conference Publication

EGF-induced recycling of the cancer promoting protein CDCP1

Adams, Mark N., Harrington, Brittney S., He, Yaowu, Davies, Claire M., Wallace, Sarah J., Chetty, Naven P., Crandon, Alexander J., Oliveira, Niara B., Shannon, Catherine M., Coward, Jermaine I., Lumley, John W., Perrin, Lewis C., Armes, Jane E. and Hooper, John D. (2015). EGF-induced recycling of the cancer promoting protein CDCP1. 15th International Biennial Congress of the Metastasis Research Society, Heidelberg, Germany, June 28th–July 1st, 2014. Dordrecht, Netherlands: Springer Netherlands. doi: 10.1007/s10585-015-9708-3

EGF-induced recycling of the cancer promoting protein CDCP1

2014

Conference Publication

Investigation of mice deficient in matriptase-2, Hfe and transferrin receptor 2 reveals a novel non-hepatic role for Tfr2 in erythropoiesis

Wallace, D. F., Secondes, E. S., Rishi, G., Ostini, L., Mcdonald, C. J., Lane, S. W., Hooper, J. D., Lopez-Otin, C. and Subramaniam, V. N. (2014). Investigation of mice deficient in matriptase-2, Hfe and transferrin receptor 2 reveals a novel non-hepatic role for Tfr2 in erythropoiesis. Australian Gastroenterology Week 2014, Broadbeach, Australia, 22-24 October 2014. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12736_6

Investigation of mice deficient in matriptase-2, Hfe and transferrin receptor 2 reveals a novel non-hepatic role for Tfr2 in erythropoiesis

2014

Conference Publication

A New Marker of Poor Outcome and Potential Therapeutic Target in Ovarian Clear Cell Carcinoma

Hooper, J., He, Y., Wu, A., Harrington, B., Davies, C., Wallace, S., Gilks, B., Perrin, L. and Armes, J. (2014). A New Marker of Poor Outcome and Potential Therapeutic Target in Ovarian Clear Cell Carcinoma. 15th Biennial Meeting of the International Gynecologic Cancer Society, Melbourne, VIC Australia, 8-11 November 2014. London, United Kingdom: Lippincott Williams and Wilkins. doi: 10.1097/01.IGC.0000457075.08973.89

A New Marker of Poor Outcome and Potential Therapeutic Target in Ovarian Clear Cell Carcinoma

2014

Conference Publication

Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancer

Harrington, B., Davies, C. M., Wallace, S. J., He, Y., Armes, J. E., Perrin, L. C. and Hooper, J. D. (2014). Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancer. London, United Kingdom: B M J Group.

Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancer

2013

Conference Publication

An Essential Role For Transferrin Receptor 2 In Erythropoiesis During Iron Restriction

Wallace, Daniel F., McDonald, Cameron J., Secondes, Eriza S., Ostini, Lesa, Rishi, Gautam, Hooper, John D., Velasco, Gloria, Ramsay, Andrew J., Lopez-Otin, Carlos and Subramaniam, V. Nathan (2013). An Essential Role For Transferrin Receptor 2 In Erythropoiesis During Iron Restriction. 55th Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 07-10, 2013. WASHINGTON: AMER SOC HEMATOLOGY.

An Essential Role For Transferrin Receptor 2 In Erythropoiesis During Iron Restriction

2013

Conference Publication

The prevalence of osteoporosis in men with prostate cancer on androgen deprivation therapy: a systematic review and meta-analysis

Lassemillante, Annie-Claude, Hooper, John, Prins, John, Doi, Suhail and Wright, Olivia (2013). The prevalence of osteoporosis in men with prostate cancer on androgen deprivation therapy: a systematic review and meta-analysis. Prostate Cancer World Congress & 14th Australasian Prostate Cancer Conference, Melbourne Australia, 6–10 August 2013. West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.12293

The prevalence of osteoporosis in men with prostate cancer on androgen deprivation therapy: a systematic review and meta-analysis

2013

Conference Publication

Clinically Identified Tmprss6 Mutations Result in Either Trafficking Defects or Inability to Cleave Hemojuvelin

Bennett, Nigel C., McDonald, Cameron J., Wallace, Daniel F., Hooper, John D., Lopez-Otin, Carlos and Subramaniam, V. Nathan (2013). Clinically Identified Tmprss6 Mutations Result in Either Trafficking Defects or Inability to Cleave Hemojuvelin. BioIron 2013: 5th Meeting of the International BioIron Society, University College London UK, April 14 – 18, 2013. Hoboken, United States: Jossey Bass, Ed. & Pub.. doi: 10.1002/ajh.23453

Clinically Identified Tmprss6 Mutations Result in Either Trafficking Defects or Inability to Cleave Hemojuvelin

2009

Conference Publication

Kallikrein-related proteases as novel therapeutic targets in prostate and ovarian cancer

Clements, J. A., Dong, Y., Loessner, D., Tan, O., Sieh, S., Reichert, J., Burke, L., Stephens, C., Lawrence, M., Stansfield, S., Swedberg, J., Ramsay, A., Hooper, J., Harris, J. and Hutmacher, D. (2009). Kallikrein-related proteases as novel therapeutic targets in prostate and ovarian cancer. 40th Annual Conference of the Society for Reproductive Biology, Clayton, VIC, Australia: CSIRO Publishing. doi: 10.1071/srb09abs009

Kallikrein-related proteases as novel therapeutic targets in prostate and ovarian cancer

2008

Conference Publication

Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)

Ramsay, Andrew J., Reid, Janet C., Adams, Mark N., Samaratunga, Hemamali, Dong, Ying, Clements, Judith A. and Hooper, John D. (2008). Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). 2nd International Symposium on Kallikrein and Kallikrein-Related Peptidases (ISK 2007), Santorini, Greece, 16-18 October 2007. Berlin, Germany: Walter de Gruyter. doi: 10.1515/BC.2008.078

Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)

2001

Conference Publication

Identification and characterization of a novel gene STAG1 is up-regulated in renal cell carcinoma

Rae, F., Hooper, J.D., Nicol, D. L. and Clements, J.A. (2001). Identification and characterization of a novel gene STAG1 is up-regulated in renal cell carcinoma. 2001 Annual Scientific Meeting of the Urological Society of Australasia, Coolum, Australia, March 2001. Australia: Blackwell Publishing Asia.

Identification and characterization of a novel gene STAG1 is up-regulated in renal cell carcinoma

2000

Conference Publication

Localization, structure and regulation of the human PRSS14 gene encoding the serine proteinase Testisin

Antalis, T. M., Boucaut, K. J., Normyle, J. F., Fitzpatrick, D. R. and Hooper, J. (2000). Localization, structure and regulation of the human PRSS14 gene encoding the serine proteinase Testisin. 91st Annual Meeting of the American Association for Cancer Research, San Francisco, 1-5 Apr, 2000. Philadelphia, U.S.A.: American Association for Cancer Research.

Localization, structure and regulation of the human PRSS14 gene encoding the serine proteinase Testisin